Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-15,300
Closed -$1.15M 1291
2021
Q2
$1.15M Sell
15,300
-4,400
-22% -$326K ﹤0.01% 978
2021
Q1
$1.3M Sell
19,700
-2,500
-11% -$173K ﹤0.01% 926
2020
Q4
$1.42M Sell
22,200
-1,100
-5% -$63.3K ﹤0.01% 919
2020
Q3
$1.21M Sell
23,300
-4,800
-17% -$272K ﹤0.01% 900
2020
Q2
$1.73M Buy
28,100
+3,100
+12% +$157K 0.01% 854
2020
Q1
$875K Buy
+25,000
New +$1.24M ﹤0.01% 875
2019
Q4
Sell
-7,100
Closed -$436K 1278
2019
Q3
$436K Buy
+7,100
New +$441K ﹤0.01% 1119
2017
Q4
Sell
-17,333
Closed -$748K 1381
2017
Q3
$748K Buy
+17,333
New +$664K ﹤0.01% 1028
2017
Q2
Sell
-43,800
Closed -$1.47M 1278
2017
Q1
$1.47M Hold
43,800
0.01% 844
2016
Q4
$1.73M Sell
43,800
-14,300
-25% -$503K 0.01% 790
2016
Q3
$1.78M Buy
58,100
+2,400
+4% +$67.4K 0.01% 785
2016
Q2
$1.38M Buy
55,700
+2,300
+4% +$59K 0.01% 818
2016
Q1
$1.41M Sell
53,400
-1,400
-3% -$34.9K 0.01% 813
2015
Q4
$1.53M Buy
+54,800
New +$1.66M 0.01% 830

Other funds holding MTRN

Axa's MTRN Position: Q3 2021 in Review

Axa sold out of Materion (MTRN) in Q3 2021, closing a stake of 15,300 shares — an estimated $1.15M sold.

Axa first reported a position in MTRN in Q4 2015 and held it in 14 quarters. The position peaked at $1.78M in Q3 2016. 181 funds tracked by Wall St. Rank hold MTRN as of Q3 2021.

  • Axa reported no remaining Materion position as of Q3 2021 after selling out during the quarter.
  • Axa sold 15,300 Materion shares in Q3 2021, an estimated $1.15M.
  • Axa first reported a position in Materion in Q4 2015 and held it in 14 quarters.
  • Axa's Materion position peaked at $1.78M in Q3 2016.
  • 181 funds tracked by Wall St. Rank held Materion as of Q3 2021.

Based on Axa's 13F filing for Q3 2021, filed 15 Nov 2021.